Antibody-mediated neutralization of Marburg virus
US11084869B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 15, 2019 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Oct 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to antibodies binding to Marburg virus (MARV) glycoprotein (GP) and methods of use therefore.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.